Stay updated on Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check27 days agoChange DetectedSite revision note updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2. This appears to be a minor site update with no changes to study details or functionality.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision updated to v3.4.1; previous revision v3.4.0 was removed.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded a glossary toggle (Show glossary) and introduced labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. Updated the page revision to v3.4.0, and removed the former wording 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check85 days agoChange DetectedThe study status updated to Active, not recruiting (revision v3.3.4). A large portion of investigator contact information and names was removed from the page.SummaryDifference9%

Stay in the know with updates to Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.